China Post-marketing Surveillance (PMS) Study of Fabrazyme®
Clinical trial NCT05054387 · COMPLETED
Trial details
- NCT number
- NCT05054387
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-13
- Primary completion
- 2023-03-09
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.